Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
519.70
Change Change %
-8.95 -1.69%

Updated:24 May, 2019, 15:56 PM IST

BSE
520.25
Change Change %
-5.00 -0.95%

Updated:24 May, 2019, 16:01 PM IST

Alembic Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'18
(₹ Cr.)
MAR'17
(₹ Cr.)
Change %
Net Profit Before Taxes 535.22 549.71 -2.64%
Adjustments for Expenses & Provisions 81.90 84.88 -3.51%
Adjustments for Liabilities & Assets -188.46 -189.44 0.52%
Cash Flow from operating activities 304.55 327.16 -6.91%
Cash Flow from investing activities -793.58 -510.97 -55.31%
Cash Flow from financing activities 497.79 -96.06 618.21%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents 8.76 -279.87 103.13%
Opening Cash & Cash Equivalents 0.69 280.56 -99.75%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 9.45 0.69 1269.57%
Top